Elizabeth Holmes exposé ‘Bad Blood’ returns to bestseller lists after Nathan Fielder documentary

John Carreyrou’s Bad Blood: Secrets and Lies in a Silicon Valley Startup has returned to Amazon’s bestseller charts following the release of You Can See Everything, a documentary about disgraced Theranos founder Elizabeth Holmes.

The 2018 book ranked No. 1 in three Amazon categories, biomedical engineering, business infrastructure and venture capital, according to Variety. It also reached No. 3,048 among all books listed by the retailer, reflecting renewed interest in the story behind one of Silicon Valley’s most notorious corporate scandals.

Directed by Nathan Fielder and Lance Oppenheim, You Can See Everything opened in cinemas nationwide on October 16, according to the report. The nearly three hour A24 documentary follows Holmes, her partner Billy Evans and their two children during the final weeks before she reported to federal prison in May 2023.

Carreyrou, a former The Wall Street Journal reporter, helped expose serious problems with Theranos’ blood testing technology through his reporting in 2015. His book examines how Holmes presented the company as a medical technology breakthrough, claiming its devices could conduct hundreds of tests using only a few drops of blood.

The technology failed to deliver as promised, and Theranos dissolved in 2018. The company had once been valued at approximately $9 billion, but its collapse became a defining cautionary tale about Silicon Valley investment and corporate accountability.

Bad Blood became a No. 1 bestseller after publication and spent more than 100 weeks on The New York Times bestseller lists. Carreyrou has also praised Fielder and Oppenheim’s documentary, with the report noting his view that their approach deserves Oscar recognition.

Holmes was convicted in 2022 of four counts of wire fraud and conspiracy connected to Theranos. She was sentenced to more than 11 years in prison and has continued to maintain her innocence.

The renewed attention highlights how the Theranos story continues to attract audiences through investigative journalism and documentary filmmaking, years after the company’s collapse.